Having trouble viewing this email? View the online version.
ISSM logo

Latest News from the ISSM - September 3, 2021 Member Login
World Meeting on Sexual Medicine 2021: Prize Application Deadline Extended to October 1st

Will you be one of the ISSM's prize winners at this year's World Meeting on Sexual Medicine?

There is still time to send in your application materials. The deadline has been extended to October 1, 2021.

Four prizes will be awarded at the virtual meeting, which will be held November 19-21, 2021:

  • The ISSM Zorgniotti-Newman Prize (USD 2500)
  • The Female Sexual Dysfunction prize (USD 2500)
  • The ISSM Emil Tanagho Prize (USD 2500)
  • The ISSM Mental Health Prize (USD 2500)

Read more about the prizes and the submission instructions. 

Don't Miss the WAS/ISSM Sexual Medicine Workshop on September 10th

We hope you'll join us, along with the World Association for Sexual Health (WAS), for a day of virtual sexual medicine workshops on September 10, 2021. 

Together, we'll be bringing you informative sessions from experts in the field. For example: 

ISSM President Annamaria Giraldi will give the opening address: "Medications Associated with Sexual Dysfunction." 

Emmanuele Jannini will present "Orgasmic and Ejaculatory Dysfunctions in Men." 

Tali Rausenbaum will discuss "Sex Therapy for Female Sexual Dysfunction." 

See more details and register today!

Q & A: More on Women and COVID-19

A few weeks ago, we added a Q & A item on the ways having and recovering from COVID-19 might affect female sexual health to our website. 

This week, we take the subject a step further and discuss the implications of lockdowns, social distancing, and pandemic-related stress on women's sexuality. 

How do health and safety protocols implemented in response to the COVID-19 pandemic affect female sexual function and health?

Is Overactive Thyroid Linked to PE?

Men with hyperthyroidism (overactive thyroid) could be at higher risk for premature ejaculation (PE), according to a recent article in Sexual Medicine Reviews

The authors analyzed 32 studies. Find out more. 

New Research Summary: Why Do Men With Peyronie's Disease Choose Xiaflex?

In a recent study, about 25% of men with Peyronie's disease chose injections of collagenase clostridium histolyticum (CCH - Xiaflex) for their treatment plan. 

What prompted them to choose this path over other options? 

Dr. Nahid Punjani, et al. address this question "Predictors of Pursuing Intralesional Xiaflex in Peyronie’s Disease Patients," first published in July in the Journal of Sexual Medicine. 

Read the summary here. 

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

ISSM | International Society for Sexual Medicine
P.O. Box 94 | 1520 AB Wormerveer | The Netherlands